Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal membrane-associated signaling and synaptic proteins refers to a broad and heterogeneous collection of proteins located at the neuronal plasma membrane, particularly concentrated within the synaptic cleft and the postsynaptic density (PSD). This category includes essential molecular components such as ionotropic and metabotropic neurotransmitter receptors, voltage-gated ion channels, cell adhesion molecules, and intracellular scaffolding proteins (Sheng & Kim, 2011, Cold Spring Harb Perspect Biol). These proteins are fundamental to the process of synaptic transmission, enabling neurons to communicate and undergo the plastic changes necessary for learning and memory (Bayer & Schulman, 2019, Nat Rev Neurosci). Dysregulation or loss of these proteins is a central feature of "synaptopathies," which include neurodegenerative conditions like Alzheimer's disease and psychiatric disorders such as schizophrenia and autism (Lepeta et al., 2016, J Neurochem). While many individual members of this group, such as the NMDA receptor or acetylcholinesterase, are successful therapeutic targets for drugs like memantine and donepezil, the term itself describes a functional proteome rather than a single target (Bayés et al., 2011, Nat Neurosci). Consequently, targeting this broad class requires high specificity to avoid disrupting the delicate balance of global neuronal signaling.
Modulation of synaptic transmission through various mechanisms including receptor antagonism, ion channel block, and enzyme inhibition.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal membrane-associated signaling and synaptic proteins.